Surgical outcomes of heart valves replacement: A study of tertiary specialized cardiac center
Niloufar
Samiei
Associate Professor, Department of Cardiology AND Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
author
Mohammad Reza
Hakimi
Cardiologist, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
author
Yalda
Mirmesdagh
General Practitioner, Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
author
Mohammad Mehdi
Peighambari
Assistant Professor, Department of Cardiology AND Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
author
Alireza
Alizadeh-Ghavidel
Associate Professor, Department of Cardiac Surgery AND Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
author
Saeid
Hosseini
Associate Professor, Department of Cardiac Surgery AND Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
author
text
article
2014
eng
BACKGROUND: Heart valve disease is a significant and increasing global problem in the developing world. The aim of this study is to evaluate the incidence of postoperative complications and mortality in patients who underwent heart valve replacement. METHODS: In this prospective study, 320 adult cases (186 females and 134 males, mean age of: 45.7 ± 15.0) with valvular heart diseases who underwent heart valve replacement at our center, from June 2011 to January 2012 were enrolled. All the required demographic, echocardiographic, and electrocardiogram data were studied. The incidence of intraoperative and early postoperative complications and mortality were evaluated. RESULTS: Among total, 96.3% of the cases underwent elective surgery. Mitral valve replacement surgery was occurred the most in 58.8% of the cases. In 11.3% of the cases, bioprosthetic valves and in 88.8% of the patients prosthetic valves were required. Early postoperative complications were occurred in 85 patients (26.6%), including: valve-related events: 7 cases, postoperative arrhythmia: 24 patients, worsening function of the repaired valve: 16 cases and general complications: 38 patients. Mortality was occurred in 25 patients (7.8%), 10 cases due to cardiac problems versus 15 patients due to non-cardiac problems. There were significant correlations between age, simultaneous valve repair and replacement, the anatomic site of the valve and the incidence of postoperative complications. Age, history of diabetes mellitus (DM), hypertension (HTN), and high grade of functional capacity were reported the significant causes of postoperative mortality. CONCLUSION: Age, DM, HTN, functional capacity and multivalve disease are significant predictors of post-valvular surgery morbidity and mortality. Keywords: Heart Valve Diseases, Cardiac Surgery, Heart Valves
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
233
237
https://arya.mui.ac.ir/article_10430_01c8026feb9befd5d007f2c383c1c431.pdf
Carotid intima-media thickness and plasma fibrinogen among subjects with metabolic syndrome: Isfahan cohort study
Zahra
Bayanfar
Resident, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute Isfahan University of Medical Sciences, Isfahan, Iran
author
Masoumeh
Sadeghi
Associate Professor, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Ramin
Heidari
Assistant Professor, Hypertension Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Mojgan
Gharipour
PhD Candidate, Department of Molecular Epidemiology, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Mohammad
Talaie
PhD Candidate, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
author
Akram
Sedaghat
Resident, Heart failure Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
text
article
2014
eng
BACKGROUND: The role of plasma fibrinogen, a key regulator of inflammation processes and increased carotid intima-media thickness (cIMT) to predict metabolic syndrome (MetS) is currently under investigation. We assessed differences in the indicators of cIMT and also plasma fibrinogen level between MetS and non-MetS subjects. We also assessed the role of these two parameters for independently relationship with MetS state. METHODS: The subjects in this cross-sectional survey were population-based samples of 93 men and women aged ≥ 35 years and over who were selected from the Isfahan cohort study, Isfahan, Iran. Fibrinogen was measured by the clotting assay of Clauss. Ultrasound studies of the carotid artery were performed to measure cIMT. MetS defined based on the National Cholesterol Education Program’s Adult Treatment Panel III. RESULTS: The mean level of plasma fibrinogen was not different in the two groups with and without MetS (240.10 ± 27.80 vs. 242.56 ± 35.82, P = 0.714), but the mean of cIMT was considerably higher in MetS group than in non-MetS group (0.85 ± 0.06 mm vs. 0.66 ± 0.09 mm, P < 0.001). Using a multivariable logistic regression model, high cIMT could effectively predict MetS state with the presence of different components of MetS (odds ratio = 17.544, 95% confidence interval: 2.151-142.860, P = 0.008). The optimal cutoff point of cIMT for discriminating these two clinical states was 0.6 mm yielding a sensitivity of 61.5% and a specificity of 59.6%. CONCLUSION: Individuals with MetS demonstrated increased cIMT values compared with those without MetS. However, high plasma fibrinogen level may not be associated with MetS state. Keywords: Metabolic Syndrome, Carotid Intima-Media Thickness, Fibrinogen, Prediction
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
238
243
https://arya.mui.ac.ir/article_10431_ac482a6f9d60b4c09a137acb1f777a09.pdf
Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment
Majid
Barekatain
Associate Professor, Psychosomatic Research Center AND Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
author
Faezeh
Zahedian
Resident, Department of Psychiatry, Isfahan University of Medical Sciences, Isfahan, Iran
author
Hedyeh
Askarpour
Resident, Department of Psychiatry, Isfahan University of Medical Sciences, Isfahan, Iran
author
Mohammad Reza
Maracy
Associate Professor, Department of Epidemiology and Biostatistics AND Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
author
Mohammad
Hashemi-Jazi
Associate Professor, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Department of Cardiology, Isfahan University of Medical Sciences, Isfahan, Iran
author
Mohammad Reza
Aghaye-Ghazvini
Isfahan Center of Health Research, Isfahan, Iran
author
text
article
2014
eng
BACKGROUND: Atherosclerosis and apolipoprotein E4 (APOE4) are known risks for Dementia. We sought to evaluate the relationship between coronary atherosclerosis and APOE4 with mild cognitive impairment (MCI). METHODS: In a case-control study, subjects with age more than 60 years and recent coronary angiography were evaluated by mini-mental state examination and neuropsychiatry Unit Cognitive Assessment Tool (NUCOG) to find the patients with MCI (n = 40) and the controls with normal cognition (n = 40). Coronary angiography records were re-assessed to find the severity of coronary artery disease by the Gensini scores. Plasma levels of APOE4 were measured. RESULTS: There were no-significant difference between the 2 groups regarding the plasma APOE4 levels (P = 0.706) and the Gensini scores (P = 0.236). Associations between the Gensini scores and the NUCOG scores in the MCI group (r = −0.196, P = 0.225) and the control group (r = 0.189, P = 0.243) were not significant. However, the interaction effect between the Gensini and the NUCOG scores based on allocation to the control or the patient groups showed statistically significant difference (F(1,67) = 4.84, P = 0.031). CONCLUSION: Although atherosclerosis has been considered as known risk factor for dementia and MCI, this study could not reveal that coronary atherosclerosis-related to declining in cognitive functioning. There was no significant association between plasma APOE4 levels and MCI. Keywords: Mild Cognitive Impairment, Coronary Artery, Angiography, Apolipoprotein E4
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
244
251
https://arya.mui.ac.ir/article_10432_0f9b1ee3185ae14163fd1b1de71f0cb2.pdf
Short term high dose atorvastatin for the prevention of contrast-induced nephropathy in patients undergoing computed tomography angiography
Hamid
Sanei
Associate Professor, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Alireza
Hajian-Nejad
Resident, Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
author
Amirreza
Sajjadieh-Kajouei
Cardiologist, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Neda
Nazemzade
Internist, Department of Nephrology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
author
Nehzat
Alizadeh
Resident, Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
author
Peyman
Bidram
Resident, Heart Failure Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Behrouz
Pourheidar
Resident, Hypertension Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
text
article
2014
eng
BACKGROUND: Statins are shown effective by some studies in preventing contrast-induced nephropathy (CIN). We evaluated the effectiveness of atorvastatin in the prevention of CIN in computed tomography angiography (CTA) candidates. METHODS: This study was conducted on patients referring for elective CTA with normal renal function. Patients received atorvastatin (80 mg/day) or placebo from 24 h before to 48 h after administration of the contrast material. Serum creatinine was measured before and 48 h after contrast material injection. CIN was defined as an increase in serum creatinine level of ≥ 0.5 mg/dl or ≥ 25% of the baseline creatinine. RESULTS: A total of 236 patients completed the study; 115 atorvastatin, 121 placebo, mean age = 58.40 ± 9.80 year, 68.6% male. Serum creatinine increased after contrast material injection in both the atorvastatin (1.00 ± 0.16-1.02 ± 0.15 mg/dl, P = 0.017) and placebo groups (1.03 ± 0.17-1.08 ± 0.18 mg/dl, P < 0.001). Controlling for age, gender, comorbidities, drug history, and baseline serum creatinine level, patients who received atorvastatin experienced less increase in serum creatinine after contrast material injection (beta = 0.127, P = 0.034). However, there was no difference between the atorvastatin and placebo groups in the incidence of CIN (4.3 vs. 5.0%, P = 0.535). CONCLUSION: In patients undergoing CTA, a short-term treatment with high dose atorvastatin is effective in preventing contrast-induced renal dysfunction, in terms of less increase in serum creatinine level after contrast material injection. Further trials including larger sample of patients and longer follow-ups are warranted. Keywords: Kidney Diseases, Multidetector Computed Tomography, Contrast Media, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atorvastatin
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
252
258
https://arya.mui.ac.ir/article_10433_6813f60f1e6fa0412a9f41dc7063d52c.pdf
Effects of oat and wheat bread consumption on lipid profile, blood sugar, and endothelial function in hypercholesterolemic patients: A randomized controlled clinical trial
Amir
Momenizadeh
Resident, Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Ramin
Heidari
Assistant Professor, Hypertension Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Masoumeh
Sadeghi
Associate Professor, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Faezeh
Tabesh
Cardiologist, Heart Failure Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Maryam
Ekramzadeh
PhD Candidate, Department of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
author
Zahra
Haghighatian
Resident, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
author
Jafar
Golshahi
Associate Professor, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
Mehdi
Baseri
Resident, Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
text
article
2014
eng
BACKGROUND: Increased lipid profile after each meal can disturb the endothelial function. The present study assessed the effects of bread supplemented with oat bran on serum lipids and endothelial dysfunction in patients with hypercholesterolemia. METHODS: This clinical trial was conducted on 60 isolated hypercholesterolemic patients. The subjects were randomly allocated to either intervention (consuming at least five daily servings of oat bread with 6 g beta-glucan) or control (receiving at least five servings of wheat bread). Anthropometric indicators, fasting blood sugar and lipid profiles ere measured at baseline and after 6 weeks (in the end of the intervention). Endothelial function was assessed using flow-mediated dilation (FMD). Within the group and between group differences were investigated using paired t-test and Student’s t-test, respectively. RESULTS: Oat bread consumption could significantly reduce total cholesterol (P = 0.029). A significant increase in baseline and after ischemia brachial artery diameters at the end of the study was seen. However, it did not have a significant effect on FMD (P = 0.825). In the control group, none of the measured indices had changed significantly at the end of the study. Finally, only the mean change of brachial artery diameter after ischemia and baseline brachial artery diameter were significantly higher in the intervention group than in the control group (P = 0.036 and P = 0.012 respectively). CONCLUSION: Oat bread with beta-glucan could successfully reduce cholesterol levels. Furthermore, in this study oat bread did not reduce FMD more than wheat bread. Since hypercholesterolemia is a proven risk factor for endothelial dysfunction, hypercholesterolemic patients can hence be advised to eat oat bread. Keywords: Bread, Diet, Flow-Mediated Dilation, Hypercholesterolemia
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
259
265
https://arya.mui.ac.ir/article_10434_34efdc45444d10df689e86bc7b4d322b.pdf
Dietary intakes and leptin concentrations
Vajihe
Izadi
Food Security Research Center AND Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
author
Sahar
Saraf-Bank
Food Security Research Center AND Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
author
Leila
Azadbakht
Food Security Research Center AND Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
author
text
article
2014
eng
BACKGROUND: Leptin, a peptide contained 146 amino-acids, is mostly secreted from adipose tissue and it has a critical role on regulation of body weight, body fat mass, appetite, and food intakes. We tried to review the previous evidence regarding the effects of dietary intakes, including consumption of carbohydrates, fats and protein on concentrations of leptin concentration. METHODS: We searched in PubMed search engine to January 2013 by using the following key words: dietary intake, diet, dietary fat, high-fat diet, dietary carbohydrate, high carbohydrate diet, dietary protein, high protein diet in combination with leptin, adipokine. Then, we recruited 35 articles to review in the present study. RESULTS: It seems that beside the amount of fats, type of fatty acids have the key roles on circulating leptin concentration. Energy intake also significantly associated with the hormone. Studies regarding the association between carbohydrate intake and concentration of lepton have been reached to contradictory results. It seems that protein intake can increase the lepton activity. CONCLUSION: Findings from several studies suggest that a diet display an important role on change the concentration of lepton. Keywords: Diet, Carbohydrate, Protein, Fat, Leptin
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
266
272
https://arya.mui.ac.ir/article_10435_8459b02345c332b0ad03a09c84e1e05d.pdf
A rare presentation of patent ductus arteriosus in an adult patient with normal pulmonary hypertension and limb edema
Bahram
Pishgoo
Associate Professor, Department of Cardiovascular Diseases, School of Medicine AND Cardiovascular Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
author
Amin
Saburi
Researcher, Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
author
Arezoo
Khosravi
Assistant Professor, Cardiovascular Research Center AND Department of Cardiovascular Diseases, School of Medicine, Baqiyatallah
University of Medical Sciences, Tehran, Iran
author
text
article
2014
eng
BACKGROUND: Patent ductus arteriosus (PDA) at childhood is one of the five major and frequent congenital abnormalities, but it can be rarely seen in adults. Pulmonary hypertension (PHTN) and other presentations such as heart failure and edema are the identified complications of longstanding PDA, but adult case with no permanent heart symptoms and PHTN was rare. We reported a rare case of with an obvious PDA and normal pulmonary pressure. CASE REPORT: A 61-year-old woman presented with dyspnea (New York Heart Association class 2), chest pain, and lower limb edema. Echocardiogram showed; normal left ventricular chamber size and function, normal size of both atria. Furthermore, an obvious PDA (diameter = 6-7 mm) connecting the aortic arch to the pulmonary artery was reported in echocardiography. No lung congestion and evidence for PHTN was reported by computed tomographic angiography [Pulmonary capillary wedge pressure (PCWP) = 30 mmHg]. The patient was treated with antihypertensive drugs and after 1 and 3 months follow-up, edema and other symptoms were resolved. CONCLUSION: Finally, we conclude that PDA in adulthood can present with nonspecific cardiovascular symptoms, and it seems that PHTN is not a fixed echocardiographic finding in these patients. Keywords: Adults, Edema, Patent Ductus Arteriosus eri, Pulmonary Hypertension
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
273
275
https://arya.mui.ac.ir/article_10436_2ea706df0346196175210f924232fd0f.pdf
Complete heart block in a patient with POEMS syndrome: A case report
Farzaneh
Ashrafi
Assistant Professor, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
author
Ali
Darakhshandeh
Resident, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
author
Pardis
Nematolahy
Pathologist, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
author
Alireza
Khosravi
Associate Professor, Interventional Cardiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
author
text
article
2014
eng
BACKGROUND: Polyneuropathy, organomegaly, endocrinopathy, monoclonal syndrome (POEMS) is a rare paraneoplastic syndrome associated with plasma cell dyscrasia. CASE REPORT: A 48-year-old man presented with a 1-year history of paresthesia and progressive weakness of extremities. Diagnosis of POEMS syndrome was made for him on the basis of clinical presentation, additional physical findings, typical sclerotic bone lesion, and bone marrow findings. In last admission, he explained episodes of dyspnea and chest pain that associated with frequent premature ventricular contraction in his electrocardiograph. Patient heart monitoring showed some episodes of complete heart block. Infra-His atrioventricular block in electro-physiologic study was detected. He had no history of ischemic heart disease. His cardiopulmonary findings on examination were normal. All results of cardiac biomarkers and serum electrolytes and repeated echocardiography were within normal range. Cong red staining of rectal fat pad biopsy was negative. After pacemaker insertion radiation of sclerotic bone, lesion started for him, but radiotherapy was ineffective, and he expired with respiratory failure. Complete heart block in POEMS syndrome has not been reported previously, and it is the first POEMS case with complete heart block. CONCLUSION: Complete heart block is a cardiac manifestation of POEMS syndrome. Keywords: Complete Heart Block, POEM Syndrome, Multiple Meloma
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
276
279
https://arya.mui.ac.ir/article_10437_ddd47ce2a32f52607d23621c59b46e0c.pdf
Investigation of the effect of short-term supplementation with curcuminoids on circulating small dense low-density lipoprotein concentrations in obese dyslipidemic subjects: A randomized double-blind placebo-controlled cross-over trial
Mohsen
Moohebati
Associate Professor, Cardiovascular Research Center AND Department of Cardiology, School of Medicine, Mashhad University of
Medical Sciences, Mashhad, Iran
author
Shima
Yazdandoust
Biochemistry of Nutrition Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
author
Amirhossein
Sahebkar
Assistant Professor, Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
author
Mohsen
Mazidi
Biochemistry of Nutrition Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
author
Zahra
Sharghi-Shahri
Biochemistry of Nutrition Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
author
Gordon
Ferns
Professor, Brighton and Sussex Medical School, Mayfield House, University of Brighton, Brighton, UK
author
Majid
Ghayour-Mobarhan
Associate Professor, Biochemistry of Nutrition Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
author
text
article
2014
eng
BACKGROUND: Small dense low-density lipoprotein (sdLDL) is a sub-fraction of LDL considered to have the most atherogenic properties. The present trial aimed to assess changes in circulating sdLDL concentrations following supplementation with curcuminoids, polyphenolic compounds with diverse potential cardio-protective functions. METHODS: This study was designed as a randomized double-blind placebo-controlled cross-over trial. A total of 30 obese dyslipidemic subjects were assigned to curcuminoids (1 g/day) or placebo for 4 weeks, followed by a 2-week washout and then treatment with the alternate for another 4 weeks. Serum sdLDL was measured at baseline and weeks 4, 6, and 10 of the trial. RESULTS: Supplementation with curcuminoids (1 g/day) did not cause any significant alteration in serum sdLDL (P > 0.05). CONCLUSION: Four-week supplementation with curcuminoids was not associated with any significant alteration in circulating sdLDL concentrations. Keywords: Diferuloylmethane, Curcuma longa L., Turmeric, Cardiovascular Disease, Hypercholesterolemia, Atherosclerosis
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
280
286
https://arya.mui.ac.ir/article_10438_88e52684597134fcfb721dc1e86f712a.pdf
Journal Index
Index
Journal
author
text
article
2014
eng
Click to download the index of this issue.
ARYA Atherosclerosis Journal
Cardiovascular research institute, Isfahan University of Medical Sciences
1735-3955
10
v.
5
no.
2014
https://arya.mui.ac.ir/article_10429_a3b003ee4cf6a2433e82bfa05665031c.pdf